Re: Long-term efficacy of sildenafil and tachyphylaxis effect [10]

Journal of Urology

Volumn 168, Issue 1, 2002, Pages 204-206

  El Galley, R ^a   Rutland, H ^a   Talic, R ^a   Keane, T ^a   Clark, H ^a   Basson, Rosemary ^a   Robinow, O ^a   Billups, Kevin L ^b   Carson, Culley C ^c   Guay, Andre T ^d   Mumtaz, F H ^e   Khan, M A ^e   Mikhailidis, D P ^e   Morgan, R J ^e   Tomera, Kevin ^f  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b Campus Box 7235 ^*  (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f Alaska Urological Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; UNCLASSIFIED DRUG; PIPERAZINE DERIVATIVE;

ADULT; COMORBIDITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ERECTILE DYSFUNCTION; HUMAN; LETTER; MALE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; TACHYPHYLAXIS; TESTOSTERONE BLOOD LEVEL; DRUG EFFECT; IMPOTENCE; LIBIDO; NOTE; PSYCHOLOGICAL ASPECT; SEXUAL COUNSELING; TREATMENT OUTCOME; RISK FACTOR;

HUMANS; IMPOTENCE; LIBIDO; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SEX COUNSELING; TACHYPHYLAXIS; TREATMENT OUTCOME; RISK FACTORS;

EID: 0036283151     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)64886-0     Document Type: Letter

References (0)